Does Dr. MATT ROSENBERG have financial conflicts of interest?

Dr. MATT ROSENBERG (M.D.) has received a total of $455,714 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $455,714 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MATT ROSENBERG?

According to CMS Open Payments data, Dr. MATT ROSENBERG received funding from SUMITOMO PHARMA AMERICA ($210,417), UROVANT SCIENCES ($88,793), and ASTELLAS PHARMA US ($87,398).

Does Dr. MATT ROSENBERG receive research grants or speaking fees?

Dr. MATT ROSENBERG has received $455,714 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MATT ROSENBERG

M.D.Real-Time Hydrated

Specialty: Family Medicine

Practice Location: JACKSON, MI 49201

NPI Number: 1730289711

LIFETIME INDUSTRY VALUE

$455,714

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ROSENBERG is a verified Family Medicine practitioner based in JACKSON, MI.

Between 2021 and 2025, Dr. ROSENBERG had an overall industry promotional and research financial footprint of $455,714 as recorded in the federal CMS Open Payments database.

$455,714 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ROSENBERG's primary funding source is SUMITOMO PHARMA AMERICA, which accounts for $210,417 (representing 46.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SUMITOMO PHARMA AMERICA

Rank 1

$210,417

46.2%

UROVANT SCIENCES

Rank 2

$88,793

19.5%

ASTELLAS PHARMA US

Rank 3

$87,398

19.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.